Alternatives to Anamnesis Bio
Anamnesis Bio is a Biotech tool: developing novel therapeutics for neurodegenerative diseases using advanced biological insights. Here are the 59 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Anamnesis Bio
Denali TherapeuticsNot ratedBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
BiotechHealthTechUpdated 13 Sept 2026
BiogenNot ratedGlobal biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.
BiotechMedTechUpdated 22 Jun 2026
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BiotechHealthTechUpdated 1 Jul 2026
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
BiotechMedTechUpdated 1 Jul 2026- LELexeo Therapeutics3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
BiotechMedTechUpdated 1 May 2026
Caris Life SciencesNot ratedCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
BiotechMedTechUpdated 25 Jun 2026
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
BiotechMedTechUpdated 28 Sept 2026
Tenaya TherapeuticsNot ratedBiotechnology company developing gene therapies and regenerative medicine for heart disease.
BiotechMedTechUpdated 16 Aug 2026
CellcolabsNot ratedAI-powered platform for personalized cell therapy development and manufacturing.
BiotechMedTechUpdated 29 Sept 2026
UltragenyxNot ratedBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
BiotechMedTechUpdated 1 Jul 2026
SyantraNot ratedA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
BiotechMedTechUpdated 26 Sept 2026
Avidity BiosciencesNot ratedClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
BiotechDrug DiscoveryUpdated 13 Sept 2026
Bluebird BioNot ratedGene therapy company developing transformative treatments for severe genetic diseases.
BiotechMedTechUpdated 9 Jul 2026
Orchard TherapeuticsNot ratedGene therapy company developing treatments for rare inherited diseases.
BiotechMedTechUpdated 28 May 2026- RIRidge Bio5.0 out of 5 (1)
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
BiotechMedTechUpdated 28 Sept 2026
MacroGenicsNot ratedBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
BiotechMedTechUpdated 30 Aug 2026- CSCSF BiosciencesNot rated
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
BiotechDrug DiscoveryUpdated 1 Jul 2026 - RERetro BiosciencesNot rated
A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.
BiotechLongevityUpdated 24 Jun 2026
Juvenescence Ltd.Not ratedBiotech company focused on developing therapies to extend human healthspan and lifespan.
BiotechHealthTechUpdated 21 Jun 2026
iSpecimen .3.0 out of 5 (1)Global marketplace connecting researchers with human biospecimens for life science research.
BiotechHealthTechUpdated 27 Jul 2026
Showing the 20 closest matches. See the rest on the Anamnesis Bio profile.